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1. Introduction 
Acute kidney injury (AKI), impairment of kidney function requires special attention in 
intensive care unit’s (ICU), because if multiorgan failure affect the kidney, it carries a greater 
risk for worse outcome and furthermore survivors have higher risk then normal population 
for chronic renal failure. It was reported that they also have higher mortality and morbidity 
rates compared to normal population (Kellum, 2008 & Shiffle, 2006).  
Acute tubular necrosis (ATN) is the primary causes of AKI in hospital and ICU and sepsis, 
ischemic or toxic insults were reported as the most common reason for ATN. The rates of 
AKI have been reported in hospitalized patients to be between 3.2%-20% and in ICUs this 
rate rises up to 22% and even to 67% depending on the population studied and the 
definition used (Murugan 2011). Based on the administrative data, the incidence of severe 
AKI (defined requiring dialysis) from 1988 to2002 has increased from 4 to 27 per 100000 
population. But fortunately in hospital mortality, has decreased from 41.3 to28 % (p<0.001) 
(Waikar, 2008). Likewise a progressive 2.8% annual increase in incidence of AKI and 
progressive 3.8% annual decrease in AKI associated mortality(95%CI:-4.7 to-2.12:p<0.001) 
was observed from 1996-2005 in a large database in Australia and New Zealand (Pisoni, 
2008&Bagshaw, 2007). Despite the fact that mortality might be decreasing in ICU patients 
with AKI, it is still high and reported to be up to 43-88%. Mortality rate becomes even higher 
when patients require renal replacement therapy (Kellum, 2008).  
Interestingly, it was reported that irreversible AKI requiring chronic dialysis therapy 
increased from 3.7% in 1984 to 18.2% in 1995 in surviving patients. Even higher number of 
patients (33-68%) at discharge whose kidney failed to recover and who needed long term 
dialysis. This changing renal outcome in the survivors of ICU acquired AKI cases might be 
related to increasing number of older patients, several co morbid conditions, more severe 
AKI cases than before and in addition, complication of the more aggressive renal 
replacement therapies currently used (Shiffle, 2006).   
Since AKI in critical ill patients have high mortality rate and even if patients survive, they 
are at risk for End Stage Renal Disease (ESRD) and higher mortality than the normal 
population, it is important to recognize the clinical picture of AKI and to institute 
prevention as early as possible. Thus, physician should be alarmed and be ready for early 
intervention in this particular group of patients. With the introduction of the RIFLE 
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classification for the definition of AKI, the viewpoint of this subject has changed and now it 
is possible to be aware of patients with high risk for AKI(Bellomo 2004). Nevertheless 
recently several biomarkers have been introduced to diagnose AKI even before creatinine 
starts to increase(Waiker, 2008).  
In this review, new perspective and favorable improvement of this subject will be discussed; 
furthermore definition, epidemiology, risk factors, biomarkers of AKI will be evaluated. 
2. Definition 
Patients in ICU comprise heterogeneous population, and around 30 different definitions 
were used to describe acute deterioration of renal failure, which both caused difficulties to 
interpret studies and to discuss the conclusions. Since even small changes in renal function 
makes prominent differences, it was suggested that re-evaluation of the definition of AKI 
was mandatory. For the consensus of the definition and improvement of the quality of 
studies on AKI, Acute Dialysis Quality Initiative (ADQI) group was established. They 
recommended the term of AKI instead of ARF, since spectrum of AKI is broader and covers 
different degrees of severity of the disease. In 2002, for a uniform definition of AKI, they 
described three categories for severity (Risk of ARF, Injury of the kidney, and Failure of 
kidney function) and two classes for kidney outcome (Loss of kidney function and ESRD), 
which is called shortly RIFLE criteria(Table1) (Bellomo, 2004). Since AKI is not a stable 
condition, definition based on changes in function seems to be more suitable. Two measures 
to reflect kidney function have been recommended for the purpose of definition of AKI; 
changes in serum creatinine level and urine output. Importantly, these criteria were 
validated based on ability to distinguish the patients with higher risk for the worst outcome 
(death and requirement for renal replacement therapy). 
The RIFLE criteria have been validated in more then 550,000 patients worldwide. Many 
studies confirmed that a rise in mortality rates occurred with progressing RIFLE criteria in 
ICU cases (Murugan, 2011). RIFLE criteria validated in a study on two Turkish tertiary 
hospital ICU population. This study also showed that increasing mortality rate with increase 
in severity, difference in mortality rate between stages was statistically significant 
(χ2=15.037, p<0.001) (Yegenaga, 2010).  
Later on in 2007, ADQI group with worldwide collaboration of nephrologists and critical 
care societies developed Acute Kidney Injury Network (AKIN), which intends to improve 
worldwide coordination and provokes the development of uniform standards in the AKI 
area. RIFLE criteria were refined by this group and reported a new AKIN classification, 
which classified AKI in three stages (stages 1, 2, and 3) according to the degree of damage 
and outcome categories Loss and ESRD were removed (Mehta, 2007). The purpose of these 
modifications were to include a small but important group of patients with early and mild 
AKI who experience a change in renal function that is greater than physiological variation 
but less than the 50% increase required for the RIFLE criteria. Thus, an absolute increase in 
serum creatinine levels of at least 0.3mg/dl in 48 hours was recommended to include in 
stage 1. Patients who required renal replacement therapy (RRT) are classified as stage 3 AKI, 
regardless of their serum creatinine levels and urine output. Nevertheless there is no 
common worldwide guideline about the timing to initiate of RRT, using it as criteria to 
describe stage 3 may cause some misunderstandings. In particular, patients with underlying 
chronic kidney disease (CKD) may be missed by the original RIFLE criteria but not by AKIN 
since it counts even smaller changes in serum creatinine level. In addition, 48-hours time  
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 Serum Creatine Criteria Urine output criteria 
RIFLE class 
Risk Serum creatine increase to 
1.5-fold OR GFR decrease 
>25% from baseline 
<0.5ml/kg/h for 6h 
Injury Serum creatine increase to 
2.0-fold OR GFR decrease 
>50% from baseline 
<0.5ml/kg/h for 12h 
Failure Serum creatine increase to 
3.0-fold OR GFR decrease 
>75% from baseline OR 
serum creatine ≥354µmol/l 
(≥4mg/dl)with an acute 
increase of at least 44µmol/l 
(0.5mg/dl) 
Anuria for 12h 
AKIN Stage 
1 Serum creatine increase ≥ 
26.5 µmol/l (0.3mg/dl) OR 
increase to 1.5-2.0-fold from 
baseline 
<0.5ml/kg/h for 6h 
2 Serum creatine increase ≥ 
2.0-3.0 fold from baseline 
<0.5ml/kg/h for 12h 
3 Serum creatine increase 
>3.0-fold from baseline OR 
serum creatine ≥354µmol/l 
(≥4.0mg/dl) with an acute 
increase of at least 44µmol/l 
(0.5mg/dl) OR need for RRT 
<0.3ml/kg/h for 24h OR 
anuria for 12h OR need for 
RRT 
Table 1. Two definitions of AKI 
interval for the diagnosis of AKI was introduced to ensure that the process is acute. Unlike 
RIFLE, in AKIN criteria there has been an attempt to resolve some easily reversible causes of 
azotemia (for example, volume depletion and urinary obstruction). AKIN criteria declare 
that diagnosis based on the urine criterion alone will require exclusion of urinary tract 
obstructions and other easily reversible causes of decreased urine output.  
Determination of baseline renal function: Since AKI was defined as rapid decline in renal 
function from baseline levels, it is important how to measure baseline renal function. The 
baseline serum creatinine level has been recommended for use as a marker to reflect the 
renal function. The baseline serum creatinine value has been estimated in various ways, 
such as the serum creatinine level on hospital admission, the minimum creatinine level 
during the hospital stay, the serum creatinine value estimated from the MDRD calculation 
(assuming estimated GFR=75ml/min/1,73m2) or the lowest value among these (Ricci, 
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2011). The choice of estimation technique used to obtain the baseline creatinine value has 
a marked effect on the prevalence of AKI, severity of disease, and mortality risk 
associated with various stages of AKI. When premorbid renal function is not known 
ADQI group has recommended back- estimation of the baseline serum creatinine level 
value using the MDRD formula. In a study, involving 4,863 hospitalized patents, 
investigators studied the performance of these three potential surrogates for the baseline 
serum creatinine level and they concluded that all three surrogates resulted in 
bidirectional misclassification of AKI. Although the use of serum creatinine level at 
admission found to be more specific in this study, this parameter had the lowest 
sensitivity (38.9%) for diagnosis of AKI (Siew, 2010).  
Subgroup analysis of data from the Beginning and Ending Supportive Therapy for the 
Kidney (BEST) study also compared observed baseline serum creatinine levels with MDRD 
back estimated values to determine the RIFLE class. They found that MDRD back estimated 
serum creatinine value performed reasonably well for the determination of the RIFLE 
categories when premorbid renal function was near normal, but should be cautiously used 
in patients with suspected CKD (Bagshaw, 2009). 
As a conclusion investigators should make every effort to find out true baseline creatinine 
level before using any estimated values. An appropriate baseline serum creatinine value 
should express normal renal function of patients, such as outpatients serum creatinine level 
measured within the past year (prefereably in the past 3 months). When an outpatient 
serum creatinine level is not available, serum creatinine level on admission to hospital or 
ICU could be used as a second choice. However, use of admission serum creatinine level is 
specific but insensitive, and may underestimate the incidence of AKI.  
Which classification is better RIFLE or AKIN? Based on the studies to compare these two 
classifications; AKIN did not seem to show any improvement in the sensitivity and 
predictive ability of the definition and classification of AKI. Acute Physiology Score 
(SAPS)3 database in 2009  re-evaluated and compared   the performance of the RIFLE and 
AKIN criteria (Joannidis, 2009). They concluded that RIFLE seems to be more sensitive for 
diagnosing AKI and to have a greater ability then AKIN criteria to predict the mortality. 
These data confirm that neither classification offers clear advantage over the other; and 
both systems still have some limitations. Similarly Bagshaw et al. compared AKIN 
classification and RIFLE criteria in 120,123 critically ill patients during the first 24 hours 
after admission to the ICU (Bagshaw, 2008). They concluded that AKIN classification did 
not improve the sensitivity and predictive ability of RIFLE criteria for the definition and 
classification of AKI in the first 24 hours in ICU. Based on these large database studies 
there is no evidence about superiority of any of these classifications. Both criteria can be 
used for the evaluation of critically ill patients, as long as the clinician is aware of the 
limitations mentioned above. 
3. Etiology and risk factors for AKI 
Early detection of AKI in ICU is crucial to perform early intervention and prevent further 
complications, thus it may be lifesaving to determine the risk factors for the impairment of 
the renal function.  
The Program to Improve Care in Acute Renal Disease (PICARD) is prospective 
observational extensive cohort study, which was done in USA from 1999 to 2001 (Mehta, 
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2004). This study revealed that, etiology of AKI was ATN (acute tubular necrosis) in 50% 
of cases with no specific determined cause. The next most common etiologies included 
nephrotoxin administration (26%), cardiac disease (20%) including myocardial infarction, 
cardiogenic shock, and congestive heart failure, ATN from hypotension (12%), sepsis 
(19%), unresolved prerenal factors (16%) and liver disease (11%). They found that 
predictors of mortality using proportional hazards Cox regression at the day of diagnosis 
of ARF were age, BUN, liver failure. At the day of consultation; age, Log urine output, 
creatinine (<2mg/dl), BUN, liver failure, ARDS (acute respiratory distress syndrome) and 
platelet count were related to mortality. When the day renal replacement therapy started, 
the predictive factors for survival were found as age, platelet count, liver failure, sepsis or 
septic shock. Oliguria, sepsis, respiratory failure, and hepatic failure would be 
consistently associated with mortality in AKI (Chertow, 2006).  
The largest cohort with most participant of AKI to date was the Beginning and Ending 
Supportive Therapy for Kidney (BEST) study (Uchino, 2005). Out of 29.269 critically  
ill patients, there were 1.738 (5.7%) patients with AKI. The most common cause of AKI  
was septic shock (47.5 %), followed by major surgery (34%), cardiogenic shock  
(27%), hypovolemia (26%) and nephrotoxin administration (19%).  In-hospital mortality 
varied from 50.5% to 76.8% between centers. A multivariate logistic regression model to 
identify independent correlates of in-hospital mortality yielded several previously 
identified risk factors, including delayed diagnosis of AKI, age, sepsis, and known disease 
severity score that included BUN and urine output, which are consistent with the 
previous studies.  
Based on the previous reports; most common and complicated cause of AKI in ICU  
was found as sepsis and its prevalence have been reported to be 9-40% (Brivet, 1996  
& Liano, 1998 & Bellomo,2008). Therefore, we prospectively evaluated 257 patients  
with sepsis or systemic inflammatory response syndrome who were admitted to the 
surgical and medical ICU during 12 months in 2001 to determine the risk factors for acute 
renal failure (ARF) development (Yegenaga, 2004). In this study, ARF was defined  
as serum creatinine level >2 mg/dL, based on this definition out of 257, twentynine (11%) 
patients were diagnosed as ARF. Mortality rate was 72% in patient with sepsis and  
ARF and in those with sepsis without ARF this rate was found as low as to 24 %. 
Multivariate logistic regression analysis of data showed that older age (OR:1.1, CI:1.03-
1.13) serum bilirubin >1.5 (OR:9.7, CI:1.65-60.3), higher baseline serum creatinine level 
(OR:1.02,CI:1.007-1.04), and higher central venous pressure (CVP) (OR:1.5,CI:1.26-1.80) 
were predictive for the development of ARF (Yegenaga, 2004). It was mandatory to 
evaluate fluid status of these patients, since it was found that CVP is an independent  
risk factor for the development of AKI (Van Biesen & Yegenaga, 2004). And subgroup 
analysis of these patients revealed that higher colloid fluid loading for the first 3  
days (2037±1681vs 1116±1220, p<0.03) and lower diuresis (1347±649vs1849±916mL, 
p=0.005) was associated with poor outcomes and in addition interestingly the fraction  
of inspired oxygen (FiO2) needed to be increased significantly on the second day of  
sepsis in the ARF group but remained unchanged in non ARF group. These patients 
developed ARF despite further fluid loading and in addition, respiratory function 
deteriorated. Against the classical knowledge; this study brought up the idea that in 
critically ill patient fluid loading should be performed in cautious. It is more likely that in 
dehydrated patients fluid loading can prevent ARF development but in critical ill patients 
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with sepsis it might bring more risk for ARF and also to increase the mortality rate 
(Payen, 2008).    
A similar study was designed previously for the Turkish ICU population of two tertiary 
hospitals, and RIFLE criteria were used for the definition of AKI (Yegenaga, 2010). In this 
Turkish ICU population, AKI incidence was 56,8% including Risk of RIFLE, and mortality 
rate was 65% in AKI and and it was found 35% in non AKI group. In this study it was 
observed that mortality rate was correlated well with the severity of RIFLE criteria; in the 
risk group 56%, in injury 68%, and in failure it was found as 72%. Multivariate logistic 
regression revealed that unlike the previous study age and serum bilirubin level were not 
significant anymore, but SOFA score (OR: 1.49, CI:1.085-2.205, p=0.045), baseline serum 
creatinine level (OR: 1.87,CI:1.391-2.520, p<0.001), and every 1 liter of extra positive fluid 
balance (OR: 1.56, CI:1.029-2.373, p=0.036) were independent risk factors for AKI. This study 
also brought up the importance of fluid overload in critically ill patients with sepsis; despite 
more vasopressor use and more fluid resuscitation, kidney damage starts very early and 
that is difficult to reverse. Previously in this particular population fluid loading was known 
as early intervention, but based on the observation in this and in some other recent reports 
fluid therapy should be performed cautiously. It is claimed that fluid overload may increase 
intra-abdominal pressure, leading to abdominal compartment syndrome, which has been 
recently recognized as an important cause of AKI in critically ill patients (Schrier, 2004). 
Furthermore fluid overload has been demonstrated to cause other organ failure in addition 
to kidney in ICU patients (Malbraina, 2005); for example impairment of cardiac function, 
worsens the lung injury (Essen, 2002).  
4. Biomarkers 
The reduction in glomerular filtration rate (GFR) is the main abnormality which is 
responsible for the clinical picture of AKI. Since serum creatinine level (SCr) is negatively 
correlated with GFR value, SCr level has been used worldwide as a marker to estimate renal 
function for years. But it is understood now that creatinine may not be appropriate marker 
for couple of reasons to measure the GFR in AKI. Addition to tubular secretion; there are 
some factors which effect serum creatinine concentration for example; age, sex, muscle 
mass, metabolism of creatinine, and volume status. Therefore the measurement of SCr level 
only has very limited utility to evaluate total kidney function. It was understood that serum 
creatinine value is neither perfectly sensitive nor specific as a biomarker to determine GFR 
value. However Cystatin C was reported recently as the best alternative to SCr as an 
endogenous GFR marker and also it is able to predict AKI 1-2 days earlier than SCr. Cystatin 
C is a low molecular weight protein produced by all nucleated cells that is freely filtered by 
the glomerulus and then reabsorbed and metabolized by the proximal tubule (Herget-
Rosenthal, 2005). Serum levels of Cystatin C are dependent not only on clearance but also on 
production rate and acute changes in volume of distribution. Higher dose of corticosteroid 
and hyperthyroidism may increase serum Cystatin C level and it may be decreased by 
hypothyroidism.   
However, tubular cell injury may precede but not always lead to a reduction of GFR. The 
relationship between functional and structural changes in the kidney is inconsistent. For 
instance, in sepsis, changes in kidney function might be severe but in contrast histological 
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findings may not be clear. The earliest sign of ischemic or nephrotoxic AKI may not be 
decreasing in GFR level, therefore in this particular condition biomarkers should be able to 
identify tubular injury even before GFR falls and increasing in serum SCr level. Furthermore 
early identification of kidney injury will be critical for future developments in treatment or 
prevention of AKI (Cruz, 2010).  
Several more biomarkers of AKI have been introduced recently, Neutrophil Gelatinase- 
Associated Lipocaline (NGAL) also known as Lipocalin-2 or siderocalin is one of the best 
studied biomarker of AKI to date. And it is rapidly up-regulated in the blood and in urine 
post-AKI. It was reported that; even though Cystatin C seems to be a better marker for AKI 
then SCr, Urine NGAL is superior to Cystatin C for earlier detection of AKI. In fact, cystatin 
C is mainly a marker of clearance, and its serum concentration may increase only after the 
GFR begins to decrease. Unlikely, NGAL which is rapidly induced in kidney tubule cells in 
response to ischemic injury, and its appearance in urine and serum is independent of the 
GFR but is highly predictive of a subsequent decline in GFR (Mishra, 2003). 
Another promising biomarker is KIM-1, a type-1 transmembrane glycoprotein that is highly 
expressed in proximal tubule cells after ischemic and nephrotoxic injury. In a study with 
patient undergoing cardiac surgery, urine KIM-1 levels peaked 12 hours after injury in AKI 
and predicted the need for dialysis or mortality in hospitalised patients. KIM-1 seems to be 
more specific to ischemic and nephrotoxic kidney injury than NGAL and it is not 
significantly affected by chronic kidney disease or urinary tract infection (Liangos, 2007).  
A pro-inflamatory cytokine IL-18 was also reported to be up-regulated and easily detected 
in the urine of animals with ischemic AKI. In a study, urine IL-18 levels were found 
markedly increased in patient with AKI but not in the patients with urinary tract infection, 
chronic kidney disease, nephritic syndrome, and prerenal failure. Urinary IL-18 showed 
sensitivty > 90% and specifity>95% for the diagnosis of AKI (Parikh, 2008). Both urine IL-18 
and NGAL were found as sequential predictive biomarkers of AKI in children undergoing 
cardiac surgery. The patients in whom AKI developed 2-3 days after surgery, urine NGAL 
peaked at 25 fold within 2 hours and declined 6 hours after surgery, whereas urine IL-18 
levels peaked 12 hours after surgery (Parikh, 2006). 
5. Conclusion 
Since AKI increases mortality rate and significantly worsens patients’ outcome, it is important 
to determine the patient with risk for AKI in ICU. The consensus has been achieved for the 
definition of AKI. This definition focuses on the association of hospital mortality, instead of 
renal failure requiring dialysis or clinical syndrome defined by pathology.  Every patient who 
is admitted to the ICU should be evaluated and categorized based on the creatinine level. 
Furthermore, close follow-up of renal function is crucial. Recently introduced biomarkers can 
be used for early diagnosis of AKI even before SCr level starts to increase. During treatment of 
these patients intensivist should be alert against fluid overload which is described as an 
independent risk factor to develop AKI. 
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